Amedisys Closes on Acquisition of RoseRock Healthcare
Amedisys Inc (AMED)
Last amedisys inc earnings: 2/18 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amedisys.com
Company Research
Source: GlobeNewswire
BATON ROUGE, La., April 01, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, has closed on its acquisition of RoseRock Healthcare, a hospice care provider in Tulsa, Oklahoma. Under the terms of the agreement, Amedisys acquired substantially all the assets of RoseRock Healthcare. RoseRock provides specialized hospice care to approximately 220 patients daily in northeastern Oklahoma. Amedisys also operates six home health care centers in Oklahoma, including a center in Tulsa. “To all the outstanding caregivers at RoseRock Healthcare – welcome to the family,” stated President and Chief Executive Officer Paul Kusserow. “You’ve joined a nationwide team committed to the same principles of honoring life through excellent patient care that have made your company so successful. I look forward to working collectively to bring the best of our combined strengths to our patients.” Amedisys is the third large
Show less
Read more
Impact Snapshot
Event Time:
AMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMED alerts
High impacting Amedisys Inc news events
Weekly update
A roundup of the hottest topics
AMED
News
- Amedisys Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Amedisys Reports First Quarter 2024 Financial ResultsGlobeNewswire
- Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- Amedisys, Inc. (NASDAQ: AMED) had its "market perform" rating re-affirmed by analysts at Raymond James.MarketBeat
AMED
Earnings
- 2/21/24 - Miss
AMED
Sec Filings
- 4/24/24 - Form 8-K
- 3/19/24 - Form 8-K
- 2/22/24 - Form 10-K
- AMED's page on the SEC website